Women Health Disease Diagnosis Treatment Market Analysis

Non-hormonal treatments for menopause symptoms include making changes to your diet, lifestyle, and using over-the-counter therapies. While hormone therapy is commonly used to treat hot flashes, there are other options available. Companies in the global menopause treatment market are expected to expand their offerings by getting approval for non-hormonal treatments. In September 2019, a study presented at a meeting of the North American Menopause Society showed promising results for a new non-hormonal medication called fezolinetant. This oral medication is currently being developed and has shown great potential in reducing moderate to severe hot flashes in women going through menopause.
The first non-hormonal treatment option became available in June 2013, thanks to Noven Pharmaceuticals, Inc. This marked an important milestone in providing women with alternatives to hormone therapy. Non-hormonal treatments for menopause symptoms offer women more choices and options to manage their symptoms without relying on hormonal medications. These treatments may include lifestyle changes such as exercising regularly, eating a healthy diet, and avoiding triggers that worsen symptoms. Over-the-counter therapies like herbal supplements and cooling sprays may also provide relief for some women.
The global menopause treatment market is expected to see growth as more companies seek regulatory approval for non-hormonal treatments. This demonstrates a growing recognition of the need for alternative options that can effectively alleviate menopause symptoms. The development of fezolinetant and other non-hormonal medications shows promising advancements in menopause treatment. These medications aim to target the specific symptoms of menopause, such as hot flashes, without the use of hormones. By expanding their footprint in the market, companies are striving to meet the diverse needs and preferences of women experiencing menopause. This can lead to increased accessibility and availability of non-hormonal treatments, ultimately improving the quality of life for women during this stage of life.